AnaptysBio, Inc. (ANAB)
67.39
+2.61
(+4.03%)
USD |
NASDAQ |
Mar 17, 16:00
67.39
0.00 (0.00%)
After-Hours: 20:00
AnaptysBio Profit Margin (Quarterly) : 45.83% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Nektar Therapeutics | -165.4% |
| Rigel Pharmaceuticals, Inc. | -- |
| Vanda Pharmaceuticals, Inc. | -246.8% |
| Esperion Therapeutics, Inc. | 36.71% |
| ACADIA Pharmaceuticals, Inc. | 96.33% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -97.37% |
| Return on Assets | -3.38% |
| Return on Invested Capital | -3.74% |
| Gross Profit Margin (Quarterly) | 99.44% |
| Operating Margin (Quarterly) | 61.80% |
| Return on Net Operating Assets | -24.97% |